Aliases & Classifications for Htlv-1 Associated Myelopathy

About this section
Sources:
65UMLS, 46NINDS, 47Novoseek
See all MalaCards sources

Aliases & Descriptions for Htlv-1 Associated Myelopathy:

Name: Htlv-1 Associated Myelopathy 46
Myelopathy, Htlv-1-Associated 47
 
Tropical Spastic Paraparesis 65

Summaries for Htlv-1 Associated Myelopathy

About this section
NINDS:46 For several decades the term ?tropical spastic paraparesis? (TSP) has been used to describe a chronic and progressive disease of the nervous system that affects adults living in equatorial areas of the world and causes

MalaCards based summary: Htlv-1 Associated Myelopathy, also known as myelopathy, htlv-1-associated, is related to psoriasis and htlv-1 associated myelopathy/tropical spastic paraparesis, and has symptoms including abnormal pyramidal signs, spastic paraparesis and myelopathy. An important gene associated with Htlv-1 Associated Myelopathy is CNTN2 (Contactin 2), and among its related pathways are Regulation of nuclear SMAD2/3 signaling and Antigen Presentation- Folding, assembly and peptide loading of class I MHC. Affiliated tissues include t cells, brain and prostate.

Related Diseases for Htlv-1 Associated Myelopathy

About this section

Diseases related to Htlv-1 Associated Myelopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 107)
idRelated DiseaseScoreTop Affiliating Genes
1psoriasis30.4HLA-A, HLA-B
2htlv-1 associated myelopathy/tropical spastic paraparesis12.8
3human t-cell leukemia virus type 110.6
4lymphoma10.3
5lung disease10.3
6periventricular leukomalacia10.2HLA-A, HLA-B
7postinfectious encephalomyelitis10.2HLA-A, HLA-B
8iridocyclitis10.2HLA-A, HLA-B
9retinitis10.2HLA-A, HLA-B
10anthracosis10.2HLA-A, HLA-B
11undetermined early-onset epileptic encephalopathy10.1HLA-A, HLA-B
12intermediate uveitis10.1HLA-A, HLA-B
13acneiform dermatitis10.1HLA-A, HLA-B
14prostate malignant phyllodes tumor10.1HLA-A, HLA-B
15acquired thrombocytopenia10.1HLA-A, HLA-B
16subcorneal pustular dermatosis10.1HLA-A, HLA-B
17lacrimal duct obstruction10.1HLA-A, HLA-B
18human herpesvirus 810.1HLA-A, HLA-B
19gonococcal iridocyclitis10.1HLA-A, HLA-B
20rheumatoid arthritis10.1
21malaria10.1
22hiv-110.1
23asthma10.1
24allergic rhinitis10.1
25avascular necrosis of the femoral head10.1
26anaplastic large cell lymphoma10.1
27anencephaly10.1
28arthritis10.1
29leukemia10.1
30neuromyelitis optica10.1
31distal arthrogryposis10.1
32metabolic acidosis10.1
33mumps10.1
34lactose intolerance10.1
35anhidrosis10.1
36pulmonary edema10.1
37uveitis10.1
38oral candidiasis10.1
39hypothyroidism10.1
40candidiasis10.1
41lutembacher's syndrome10.1
42ovarian cancer10.1
43dermatitis10.1
44interstitial lung disease10.1
45hyperglycemia10.1
46rhinitis10.1
47myositis10.1
48connective tissue disease10.1
49t-cell leukemia10.1
50thyroiditis10.1

Graphical network of the top 20 diseases related to Htlv-1 Associated Myelopathy:



Diseases related to htlv-1 associated myelopathy

Symptoms for Htlv-1 Associated Myelopathy

About this section

HPO human phenotypes related to Htlv-1 Associated Myelopathy:

id Description Frequency HPO Source Accession
1 abnormal pyramidal signs HP:0007256
2 spastic paraparesis HP:0002313
3 myelopathy HP:0002196

Drugs & Therapeutics for Htlv-1 Associated Myelopathy

About this section

Drugs for Htlv-1 Associated Myelopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 42)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Pentoxifyllineapproved, investigationalPhase 3906493-05-64740
Synonyms:
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
AKOS000541484
Agapurin
Agapurin Retard
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL-191
BL191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT-0201
EHT-201
EHT0201
EINECS 229-374-5
EU-0100936
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
Hemovas
I06-1592
IDI1_000729
IN1161
Ikomio
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
LS-149385
 
Lopac-P-1784
Lopac0_000936
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
PENTOXYPHYLINE
PNX
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
Pentoxyphyllin
Pentoxyphylline
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Prestwick_608
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
SPECTRUM1503611
SR-01000075641-4
STK177321
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
Spectrum_001444
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
cis-9-Octadecenoyl coenzyme A
pentoxifylline
2
Valproic Acidapproved, investigationalPhase 331199-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
3
Miconazoleapproved, investigationalPhase 2, Phase 3302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
4
Lamivudineapproved, investigationalPhase 2, Phase 3594134678-17-460825
Synonyms:
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-3TC
(+/-)-BCH-189
(+/-)-SddC
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-2'-Deoxy-3'-thiacytidine
(-)-BCH 189
(-)-BCH-189
(-)-SddC
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
(-)NGPB-21
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
134678-17-4
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
3'-Thia-2',3'-dideoxycytidine
3-TC
3TC
3TC & GNA
3TC & SST
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
3TC and NV-01
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
480434-79-5
AC-1416
AC1L1TZZ
AC1Q6C34
BCH 189
BCH-189
BCH-790
BCH189
BIDD:GT0033
Bio-0652
C07065
C8H11N3O3S
CCRIS 9274
CHEBI:133986
CHEMBL141
CID60825
CPD000466319
D00353
D019259
DB00709
 
DRG-0126
DTHC
Epivir
Epivir (TN)
Epivir HBV
Epivir(TM)
Epivir-HBV
Epzicom
FT-0082667
GG-714
GR 109714 X
GR 109714X
GR-109714X
GR109714X
HHA & 3TC
HHA & Lamivudine
HMS2051D21
HSDB 7155
Hepitec
Heptivir
Heptodin
Heptovir
L0217
LMV
LS-2107
Lamivir
Lamivudin
Lamivudina
Lamivudine
Lamivudine & GNA
Lamivudine (JAN/USP/INN)
Lamivudine [USAN:BAN:INN]
Lamivudine [USAN:INN:BAN]
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-Isomer
Lamivudinum
MLS000759424
MLS001424097
MolPort-002-507-347
NCGC00159341-03
NCGC00159341-04
NSC620753
S1706_Selleck
SAM001246582
SAM002589994
SMR000466319
STK801940
UNII-2T8Q726O95
ZINC00012346
Zeffix
Zefix
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
lamivudine
5
ZidovudineapprovedPhase 2, Phase 3, Phase 049130516-87-135370
Synonyms:
-Azido-3&prime
-deoxythymidine
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine
3&prime
3' Azido 2',3' Dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-Dideoxythymidine
3'-Azido-3'-deoxythymidine
3'-Azido-3'-deoxythymidine & Concanavalin A
3'-Azido-3'-deoxythymidine & Erythropoietin
3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19
3'-Azido-3'-deoxythymidine & Interleukin-1
3'-Azido-3'-deoxythymidine & Interleukin-2
3'-Azido-3'-deoxythymidine & Interleukin-6
3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6
3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon
3'-Azido-3'-deoxythymidine & Sho-Saiko-To
3'-Azido-3'-deoxythymidine (AIDS)
3'-Azido-3'deoxythymidine & Interferon .alpha.
3'-Azidothymidine
3'-Deoxy-3'-azidothymidine
3'-azido-3'-deoxythymidine, AZT
3-Azido-3-deoxythymidine
30516-87-1
399024-19-2
A2169_SIGMA
AC1L1TKL
AC1Q2OEK
AZT
AZT & CD4(178)-PE 40
AZT & Colony-stimulating factor 2
AZT & Concanavalin A (ConA)
AZT & EPO
AZT & GM-CSF
AZT & HPA
AZT & IFN.alpha.
AZT & IL-1
AZT & IL-2
AZT & IL-6
AZT & Interferon-.alpha.-2
AZT & Li & EPO
AZT & Li & GM-CSF
AZT & Li & IL-1
AZT & Li & IL-6
AZT & Lymphoblastoid Interferon
AZT & NP (from PHCA or HSA)
AZT & PM-19
AZT & SST
AZT & rIFN.alpha.2
AZT & rsCD4 & rIFN.alpha.A
AZT & rsT4
AZT & sCD4
AZT & srCD4
AZT (Antiviral)
AZT Antiviral
AZT TRANSPLACENTAL CARCINOGENESIS STUDY
AZT+PRO 140
AZT, Antiviral
Antiviral AZT
Apo-Zidovudine
Azidothymidine
Aztec
BB_NC-1012
BPBio1_000403
BRD-K72903603-001-04-6
BSPBio_000365
BSPBio_003153
BW A509U
BW-A 509U
BW-A-509U
BW-A509U
BWA 509U
BWA-509U
BWA509U
C07210
CCRIS 105
CHEBI:10110
CHEBI:127307
CHEMBL129
CID35370
CPD000058351
 
Compound S
Cpd S
D00413
D015215
DB00495
DRG-0004
DS-4152 & AZT
DivK1c_000524
HMS1921J20
HMS2090G11
HMS2092D06
HMS501K06
HSDB 6515
IDI1_000524
Interferon AD + 3'-azido-3'-deoxythymidine
Intron A & AZT
K7 [P Ti2 W10 O40]
KBio1_000524
KBio2_001828
KBio2_004396
KBio2_006964
KBio3_002653
KBioGR_000703
KBioSS_001828
LS-1159
Liposomal AZT-SN-1
Liposomal AZT-SN-3
MLS000028548
MLS001055351
MLS001076358
MLS002153202
MLS002222249
Met-SDF-1.beta. & AZT
Met-SDF-1.beta. & Zidovudine
MolPort-002-507-286
NCGC00023945-03
NCGC00023945-04
NCGC00023945-05
NCGC00023945-08
NCGC00178237-01
NCGC00178237-02
NINDS_000524
NSC 602670
Novo-Azt
PC-SOD+AZT
Prestwick3_000333
Propolis+AZT
Racemic Liposomal AZT
Retrovir
Retrovir (TN)
Retrovir(TM)
SAM002548971
SMR000058351
SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SPBio_000834
SPECTRUM1502109
STK801891
Spectrum2_000927
Spectrum3_001507
Spectrum4_000332
Spectrum5_001101
Spectrum_001348
UNII-4B9XT59T7S
ZDV
ZIDOVUDINE [AZT]
ZINC03779042
ZVD
Zidovudin
Zidovudina
Zidovudina [Spanish]
Zidovudine
Zidovudine (JAN/USP/INN)
Zidovudine EP III
Zidovudine [USAN:INN:BAN:JAN]
Zidovudine+PRO 140
Zidovudinum
Zidovudinum [Latin]
antiviral
azidodeoxythymidine
rIFN-beta seron & AZT
racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
zidovudin
zidovudine
6Anti-Infective AgentsPhase 2, Phase 3, Phase 017220
7Neurotransmitter AgentsPhase 314795
8Central Nervous System DepressantsPhase 310016
9Vasodilator AgentsPhase 32926
10Tranquilizing AgentsPhase 33597
11Radiation-Protective AgentsPhase 3333
12Phosphodiesterase InhibitorsPhase 31062
13Antimanic AgentsPhase 3663
14Protective AgentsPhase 35651
15AntioxidantsPhase 32442
16Platelet Aggregation InhibitorsPhase 31935
17Psychotropic DrugsPhase 35501
18Nucleic Acid Synthesis InhibitorsPhase 2, Phase 3, Phase 03836
19Reverse Transcriptase InhibitorsPhase 2, Phase 3, Phase 01656
20Antiviral AgentsPhase 2, Phase 3, Phase 08071
21Anti-Retroviral AgentsPhase 2, Phase 3, Phase 02794
22AnticonvulsantsPhase 32249
23Antifungal AgentsPhase 2, Phase 33015
24AntimetabolitesPhase 2, Phase 3, Phase 09454
25Immunosuppressive AgentsPhase 2, Phase 310422
26Antirheumatic AgentsPhase 2, Phase 38496
27Dermatologic AgentsPhase 2, Phase 34555
28Immunologic FactorsPhase 2, Phase 318483
29Calcineurin InhibitorsPhase 2, Phase 31223
30CyclosporinsPhase 2, Phase 3873
31
Interferon beta-1aapproved, investigationalPhase 2194145258-61-36438354
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Avonex Pen
Belerofon
D04554
Extavia
 
Fibroblast interferon
IFN-beta
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (USAN)
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
Rebif
Rebif Rebidose
32
InfliximabapprovedPhase 2349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
33interferonsPhase 21930
34Interferon-betaPhase 2253
35Adjuvants, ImmunologicPhase 21783
36Gastrointestinal AgentsPhase 26401
37ImmunoglobulinsPhase 14477
38Antibodies, MonoclonalPhase 12413
39AntibodiesPhase 14477
40Raltegravir PotassiumPhase 0288
41HIV Integrase InhibitorsPhase 0343
42Integrase InhibitorsPhase 0370

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised TrialCompletedNCT00272480Phase 2, Phase 3
2Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)CompletedNCT00773292Phase 2, Phase 3
3Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)CompletedNCT00681980Phase 3
4Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) DiseasesCompletedNCT01472263Phase 3
5Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)Active, not recruitingNCT01343355Phase 2, Phase 3
6Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)CompletedNCT00001785Phase 2
7Ruxolitinib for Adult T-Cell LeukemiaRecruitingNCT01712659Phase 2
8The HAM Infliximab StudyTerminatedNCT00823641Phase 2
9Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisRecruitingNCT00076843Phase 1
10MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic ParaparesisCompletedNCT00034723
11A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective DermatitisCompletedNCT00340821
12Assessment of Patients With Multiple Sclerosis (MS)CompletedNCT00001156
13Raltegravir for HAM/TSPRecruitingNCT01867320Phase 0
14Evaluation of Patients With HAM/TSPRecruitingNCT00001778
15Urological Physical Therapy in HTLV-1 With Urinary SymptomsEnrolling by invitationNCT01651819
16Evaluation of the MP Diagnostics HTLV Blot 2.4Enrolling by invitationNCT01467024
17Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 InfectionNot yet recruitingNCT02655471Phase 0
18Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1Not yet recruitingNCT01754311
19Safety and Efficiency Study of Valproic Acid In HAM/TSPTerminatedNCT00519181

Search NIH Clinical Center for Htlv-1 Associated Myelopathy

Genetic Tests for Htlv-1 Associated Myelopathy

About this section

Anatomical Context for Htlv-1 Associated Myelopathy

About this section

MalaCards organs/tissues related to Htlv-1 Associated Myelopathy:

33
T cells, Brain, Prostate, Thyroid, Salivary gland, B cells, Placenta

Animal Models for Htlv-1 Associated Myelopathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Htlv-1 Associated Myelopathy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Htlv-1 Associated Myelopathy

About this section

Articles related to Htlv-1 Associated Myelopathy:

(show top 50)    (show all 52)
idTitleAuthorsYear
1
Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma. (25793736)
2015
2
The cAMP-responsive element binding protein (CREB) transcription factor regulates furin expression during human trophoblast syncytialization. (25175744)
2014
3
Phase II study of low-dose fixed-rate infusion of gemcitabine combined with cisplatin and dexamethasone in resistant non-Hodgkin lymphoma and correlation with Bcl-2 and MDR expression. (24496564)
2014
4
CD14 -159 C>T gene polymorphism with increased risk of tuberculosis: evidence from a meta-analysis. (23741383)
2013
5
Primary giant cardiac cavernous hemangioma in right mediastinum. (23871890)
2013
6
CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms. (23419168)
2013
7
The effect of topical cyclosporine 0.05% on dry eye after cataract surgery. (23730108)
2013
8
Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a (13)C NMR study. (24220168)
2013
9
Morvan syndrome: after scrotal sac drainage and chemical instillation in hydrocele. (23860152)
2013
10
Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy. (22971989)
2012
11
Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. (21743397)
2012
12
Radiology quiz case 2. Pilomatrixoma. (21576567)
2011
13
Facilitation of I1-opioid receptor activity by preventing I'-opioid receptor-mediated codegradation. (21220103)
2011
14
Inferior vena cava obstruction by a cardiac mass: unusual presentation of primary antiphospholipid syndrome. (21480144)
2011
15
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. (20423998)
2010
16
Anatomic, imaging, and clinical characteristics of double-inlet, double-outlet right ventricle. (20152252)
2010
17
The inherent processivity of the human de novo methyltransferase 3A (DNMT3A) is enhanced by DNMT3L. (20630873)
2010
18
Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells. (19725825)
2009
19
Use of cidofovir for treatment of recurrent respiratory papillomatosis. (19221249)
2009
20
Pleomorphic corneal sarcoma resembling malignant peripheral nerve sheath tumor in a horse. (19176499)
2009
21
Pilocytic astrocytoma as a predominant component of a recurrent complex type DNT. (19813149)
2009
22
Recurrence of primary hyperparathyroidism following spontaneous remission with intracapsular hemorrhage of a parathyroid adenoma. (18470672)
2008
23
Risperidone-induced neuroleptic malignant syndrome in neurodegenerative disease: a case report. (17632663)
2007
24
Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein. (17496144)
2007
25
Markers of antioxidant defence system and lipid peroxidation in peripheral blood of female patients with chronic idiopathic urticaria. (17171548)
2007
26
Microscopic polyangiitis or Wegener's granulomatosis? That is the question. (16548912)
2006
27
Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. (16926422)
2006
28
Proliferative and apoptotic markers in prostate carcinoma in relation to androgen receptor]. (16955559)
2006
29
Comparison of cytokine plasma levels in human African trypanosomiasis. (16640617)
2006
30
Radiology case of the month. Gait disturbance. Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). (15554090)
2004
31
A low-molecular-weight factor in human milk whey promotes iron uptake by Caco-2 cells. (14704299)
2004
32
Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. (15242342)
2004
33
IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function. (12973698)
2003
34
Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells. (11964141)
2002
35
AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. (11518798)
2001
36
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. (10705076)
2000
37
Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. (11071850)
2000
38
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. (9365156)
1997
39
Endogenous opioid peptides in parasympathetic, sympathetic and sensory nerves in the guinea-pig heart. (8625399)
1996
40
Integrins beta 5, beta 3 and alpha v are apically distributed in endometrial epithelium. (9239663)
1996
41
Natural rubber latex contact dermatitis with features of erythema multiforme. (8896966)
1996
42
A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene. (7623814)
1995
43
Pathogenesis and therapy of multiple sclerosis. The role of cytokines]. (7715757)
1995
44
Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection. (1538281)
1992
45
Effect of sandostatin on CRF-stimulated secretion of ACTH, beta-lipotropin and beta-endorphin. (1651895)
1991
46
Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies. (1693591)
1990
47
Autosomal dominant microcephaly. (490235)
1979
48
Hyaluronuria in a case of progeria. (Hutchinson-Gilford syndrome). (659773)
1978
49
Barnyard fowl as a source of human ornithosis. (15426984)
1950
50
Case of Placenta Praevia. (20793851)
1845

Variations for Htlv-1 Associated Myelopathy

About this section

Expression for genes affiliated with Htlv-1 Associated Myelopathy

About this section
Search GEO for disease gene expression data for Htlv-1 Associated Myelopathy.

Pathways for genes affiliated with Htlv-1 Associated Myelopathy

About this section

Pathways related to Htlv-1 Associated Myelopathy according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.3MYC, VDR
29.1HLA-A, HLA-B
38.7CNTN2, HLA-A, HLA-B
48.6HLA-A, HLA-B, MYC
58.6HLA-A, HLA-B, MYC

GO Terms for genes affiliated with Htlv-1 Associated Myelopathy

About this section

Cellular components related to Htlv-1 Associated Myelopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell surfaceGO:00099869.1HLA-A, HLA-B

Biological processes related to Htlv-1 Associated Myelopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protection from natural killer cell mediated cytotoxicityGO:00422709.5HLA-A, HLA-B
2positive regulation of T cell mediated cytotoxicityGO:00019169.4HLA-A, HLA-B
3antigen processing and presentationGO:00198829.2HLA-A, HLA-B
4interferon-gamma-mediated signaling pathwayGO:00603339.1HLA-A, HLA-B
5antigen processing and presentation of peptide antigen via MHC class IGO:00024748.8HLA-A, HLA-B

Molecular functions related to Htlv-1 Associated Myelopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426059.1HLA-A, HLA-B

Sources for Htlv-1 Associated Myelopathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet